Last update:
Oncology & Cancer news
Oncology & Cancer
'Ready-made' T-cell gene therapy tackles 'incurable' T-cell leukemia
A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in helping children and adults fight a rare ...
6 hours ago
0
2
Oncology & Cancer
Childhood leukemia aggressiveness depends on timing of genetic mutation, research reveals
A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same leukemia-causing gene mutation can have dramatically different outcomes: It depends on when in development the ...
6 hours ago
0
0
Reversing treatment resistance in prostate cancer: Study solves longstanding puzzle in tumor biology
Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, reported in the current ...
9 hours ago
0
68
Pancreatic cancer cells 'speak the language' of organs they will later invade, study reveals
Even as they develop at their primary site, pancreatic cancer cells are already expressing the genes that will determine where they will metastasize, according to new findings from Columbia researchers. The work, published ...
9 hours ago
0
18
A routine blood test could help predict who benefits most from CAR T-cell therapy
Measuring the lymphocytes—white blood cells that fight infection—in a patient's blood can be used to predict outcomes in non-Hodgkin lymphoma patients who receive CAR T-cell therapy, according to research from physicians ...
6 hours ago
0
0
Hidden metabolic weakness in blood cancers revealed by new mapping tool
Scientists from Duke-NUS Medical School and their international collaborators have developed a new computational tool that maps how gene pathways interact in complex biological systems. Using this novel algorithm, the team ...
11 hours ago
0
0
Anti-platelet drug can slow metastasis in aggressive cancers, research shows
Aggressive cancers can use blood vessels like roadways, speeding through the body and finding new places to grow. But new research shows that a drug in clinical trials may help stop the spread of cancer before it reaches ...
10 hours ago
0
0
An existing drug may improve ovarian cancer treatment
Hua-Ying Fan, PhD, hopes that her team's latest discovery could help the almost 21,000 people who are expected to receive an ovarian cancer diagnosis this year.
5 hours ago
0
0
New combination approach aims to make CAR T more durable in lymphoma
A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may sharply boost one-year progression-free survival for people with aggressive lymphoma.
6 hours ago
0
0
Most people trust doctors more than AI but see its potential for cancer diagnosis, study finds
New research on public attitudes toward AI indicates that most people are reluctant to let ChatGPT and other AI tools diagnose their health condition, but see promise in technologies that use AI to help diagnose cancer. These ...
7 hours ago
0
0
What's the difference between a tumor and cancer?
The terms tumor and cancer can refer to different types of lumps and bumps. But the terms are often confused and misused—by the general public and even health professionals.
3 hours ago
0
0
Novel AI technique can distinguish between progressive brain tumors and radiation necrosis
While targeted radiation can be an effective treatment for brain tumors, subsequent potential necrosis of the treated areas can be hard to distinguish from the tumors on a standard MRI. A new study published today led by ...
6 hours ago
0
0
Milder chemotherapy proves effective for rare, aggressive lymphoma
Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the intensive chemotherapy often used, according to new research from Sylvester Comprehensive Cancer Center, ...
7 hours ago
0
0
Continuous and fixed-duration treatments result in similar outcomes for chronic lymphocytic leukemia
According to a new trial, patients with chronic lymphocytic leukemia (CLL) show comparable outcomes whether they receive a single-agent treatment indefinitely or a combination treatment for a fixed period of time.
11 hours ago
0
0
Childhood cancer catalog opens door to pediatric immunotherapy
A unique facility in Melbourne containing hundreds of childhood cancer tissue samples has produced a first-of-its-kind catalog of pediatric cancers to help identify how the immune system can target each one.
12 hours ago
0
0
AI is improving colon cancer diagnosis accuracy, study finds
A recent study reveals that integrating Artificial Intelligence (AI) into colon cancer diagnosis over the past five years has significantly improved the speed and accuracy of the detection of the deadly disease.
9 hours ago
0
0
Buying a gift for a loved one with cancer? Skip the fuzzy socks and give them meals or help with laundry instead
The season of gifting is in full swing—a time when people scour the internet and shops of all kinds for items that appropriately symbolize their relationships with their loved ones.
3 hours ago
0
0
New trial shows early signs that 'off-the-shelf' CAR T-cell therapy could transform treatment of myeloma
Research presented December 8 at the American Society of Hematology Conference in Florida, has shown that a new kind of CAR T-cell therapy, which generates CAR T-cells inside the body, could offer a faster, easier and more ...
11 hours ago
0
0
GLP-1 receptor agonists likely have little or no effect on obesity-related cancer risk, research shows
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.
5 hours ago
0
0
The world is facing a cancer crisis that's hitting the most vulnerable hardest
When I worked on the latest Global Burden of Disease cancer study, a global project that tracks cancer patterns and deaths across countries, I found myself pausing as the numbers loaded on the screen. Even as a scientist ...
5 hours ago
0
0
Delayed toxicities after CAR T cell therapy for multiple myeloma are connected and potentially preventable
Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, are associated with high ...
12 hours ago
0
0
Liver cancer prevention, treatment efforts are working
Prevention and treatment advances are reducing the number of new liver cancer patients and narrowing survival gaps among racial groups, a Cedars-Sinai Cancer study published in the journal Clinical Gastroenterology and Hepatology ...
14 hours ago
0
0
Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction chemotherapy. The azacitidine–venetoclax ...
15 hours ago
0
0
New findings support a chemo-free approach for treating Ph+ ALL
A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial, which included adult ...
15 hours ago
0
0
Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab in addition to the standard ...
15 hours ago
0
0
